Mednet Logo
HomeRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

Should all patients with suspected giant cell arteritis get a PET scan to look for large vessel disease?

3 Answers

Mednet Member
Mednet Member
Rheumatology · Medical College of Wisconsin Affiliated Hospitals

PET-CT and PET-MRI can be very useful diagnostic modalities in GCA, but I do not recommend universal screening with PET scanning. The upcoming ACR/VF sponsored vasculitis guidelines will likely recommend obtaining non-invasive vascular imaging to evaluate for large vessel involvement, but the recom...

How do you weigh the risks and benefits of GLP-1 RAs in patients over age 65 specifically in regards to loss of muscle mass and osteoporosis?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Sorbonne Université

This is indeed a crucial question: rapid weight loss is accompanied not only by a loss of adipose tissue but also by a loss of lean mass, including muscle and bone tissue. This must therefore be taken into account when making decisions, particularly in patients with osteoporosis, frailty, sarcopenic...

What lab monitoring and frequency do you recommend in an otherwise healthy young patient on biologics for psoriasis?

3
4 Answers

Mednet Member
Mednet Member
Dermatology · Duke Health

Yearly QuantGold testing in low risk patients has been shown to be unnecessary and actually carries a significantly higher risk of false positive than true positive. Unfortunately, many insurers still require yearly testing. I don't know of any data to support any other yearly lab testing for the dr...

How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?

12
2 Answers

Mednet Member
Mednet Member
Psychiatry · Massachusetts General Hospital/Brigham and Women’s Hospitals

In many cases, the point at which this question is being asked is one at which the train has already left the station, and sickness as a way of life/career has set in. Unfortunately, with functional somatic syndromes, there is data suggesting that self-rated quality of life and functioning are lower...

How do you make the decision to empirically treat for GCA when a patient is referred but cannot be immediately seen in clinic?

4
4 Answers

Mednet Member
Mednet Member
Rheumatology · Massachusetts General Hospital

This is an important question because referrals for possible GCA are common scenarios when a rheumatologist may be asked to recommend a treatment before seeing the patient which are often challenging scenarior. The factors I typically rely on to rate the probability of GCA include: - Specific sympto...

Do you ever consider tapering off steroid-sparing agents in patients with stable non-IPF ILD?

4
2 Answers

Mednet Member
Mednet Member
Pulmonology · Massachusetts General Hospital

In short, the answer is YES—I always look for ways to reduce immunosuppression exposure over time and use the lowest effective dose required to keep a patient’s inflammatory ILD in check. I often remind myself that when these patients present with a mixture of fibrotic changes (e.g., traction bronch...

How do you ensure that fibromyalgia is appropriately recognized in patients with Sjogrens?

2
3 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

I like Dr. Pisetsky et al's recent recommendation of naming this "nociplastic pain" rather than fibromyalgia. They were specifically talking about "lupus-associated nociplastic pain", but after reading their article, it should also apply to Sjogren's disease.I'd encourage everyone to read their very...

How do you counsel a patient with Sjogren's and extremely dry mouth who is losing their ability to taste food?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

Agree with Dr. @Dr. First Last, and we cannot overemphasize the candidiasis part. Have a very low threshold for treating candidiasis while at the same time maximizing salivary stimulation (pilocarpine, cevimeline, bethanechol). When severe xerostomia occurs, as in the question, atypical presentation...

What were your top takeaways in SLE from ACR Convergence 2025?

2 Answers

Mednet Member
Mednet Member
Rheumatology · MUSC Health

My takeaways were excitement about obintuzumab being approved, the question as to what level of proteinuria justifies biopsy, different new biomarkers regarding lupus nephritis, plus the ongoing chaos regarding CART and its spin-offs.

What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · Tidalhealth

A workup to rule out secondary causes must be done prior to starting therapy for osteoporosis. A good history and exam are recommended to look for any clues for modifiable factors. At a minimum, one should do CMP, 25-OH vitamin D, TSH, and a 24-hour urinary calcium or calcium/creatinine ratio should...